🔓
Sign in as a Member to unlock the full view of VTRS. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
VTRS

Viatris Inc.

Sector: healthcareDrug Manufacturers - Specialty & GenericNASDAQMarket Cap: $18.34B

Viatris Inc. is a global healthcare company focused on generics and biosimilars, with its primary political signal being a direct equity holding by a former president ($1,001-$15,000) and a single congressional purchase.

Next filing → your inbox
Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat VTRS does

Viatris operates as a global pharmaceutical company formed from the merger of Mylan and Upjohn. Its business model centers on developing, manufacturing, and commercializing a broad portfolio of generic, branded, and complex generic medicines, including biosimilars. Revenue is derived from sales across multiple therapeutic areas and geographic markets.

12 months past · 3 months futureVTRS activity timeline

$22$16$10 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $21.06 hi $10.19 lo $20.82 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Gilbert Ray Cisneros (D) · Purchase · 2025-11-18 Citadel Advisors · holds $95M · 2025-12-31AQR Capital Management · OPENED $84M · 2026-03-31D.E. Shaw & Co. · holds $75M · 2025-12-31AQR Capital Management · - $75M · 2026-06-30Citadel Advisors · - $72M · 2026-03-31D.E. Shaw & Co. · - $52M · 2026-03-31Bridgewater Associates · + $27M · 2026-06-30Point72 Asset Management · OPENED $24M · 2026-03-31Citadel Advisors · - $22M · 2026-06-30Bridgewater Associates · - $18M · 2025-12-31D.E. Shaw & Co. · - $13M · 2026-06-30Point72 Asset Management · - $10M · 2026-06-30Bridgewater Associates · - $10M · 2026-03-31Renaissance Technologies · OPENED $7M · 2026-09-30 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 1 congressional trades shown · 0 insider buys · 14 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsVTRS held by Trump-administration officials

Lifetime Government AwardsVTRS federal contracts

VTRS doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding VTRS

$158.0M
Total VTRS held by tracked 13F funds
7
Funds with VTRS positions
+1
Funds opened this quarter
AQR Capital Management $75M -26% 2026-06-30
Bridgewater Associates $27M +134% 2026-06-30
Citadel Advisors $22M -74% 2026-06-30
D.E. Shaw & Co. $13M -80% 2026-06-30
Point72 Asset Management $10M -65% 2026-06-30
Renaissance Technologies $7M opened 2026-09-30
Two Sigma Investments $4M +35% 2026-06-30

Politicians Trading VTRSMembers of Congress with recent VTRS positions

4 politicians traded VTRS across 16 disclosed transactions totaling $128K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just VTRS). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading VTRS

2025-11-18 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-04-22 John Fetterman D-Pennsylvania · senate Sale $1,001 - $15,000
2025-04-23 Ro Khanna D-California · house purchase $1,001 - $15,000
2025-04-23 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-04-08 Robert P. Bresnahan R-Pennsylvania · house sale $1,001 - $15,000
2025-04-08 Robert P. Bresnahan R-Pennsylvania · house Sale $1,001 - $15,000
2025-03-31 Gilbert Ray Cisneros D-California · house sale $1,001 - $15,000
2025-03-31 Gilbert Ray Cisneros D-California · house Sale $1,001 - $15,000
2025-02-25 Robert P. Bresnahan R-Pennsylvania · house purchase $1,001 - $15,000
2025-02-25 Robert P. Bresnahan R-Pennsylvania · house Purchase $1,001 - $15,000
2025-02-19 Ro Khanna D-California · house sale $1,001 - $15,000
2025-02-25 Ro Khanna D-California · house sale $1,001 - $15,000
30+ trades on file · most recent 2025-12-15

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

2
option exercises · $424K
For VTRS, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting VTRSLive legislation impacting this stock

Political ProfileWhere VTRS sits in Washington

[object Object]

STRUCTURAL: No lobbying spend (`get_political_influence.lobbying.total_income`: $0), no donations, no federal contracts. EVIDENTIARY: Direct equity holding by Donald J. Trump (`get_executive_branch_exposure.by_ticker[0].holdings`) and one congressional purchase. Net: Signals are isolated and not supported by broader political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • High exposure to healthcare pricing and drug approval legislation
    Congress, HHS, FDA
    "`Recent bill_impacts` shows 8 healthcare bills with material estimated revenue impacts, ranging from $3.19M to $6.06M."

Regulatory opportunities

  • Potential for favorable generic/biosimilar policy in pending bills
    Congress, FDA
    "`Recent bill_impacts` indicates multiple active healthcare bills, though specific carveouts for VTRS are absent (`Recent bill_carveouts` is empty)."

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

  • No specific congressional critics identified.
Member intelligence layer

Live signals + predictions for VTRS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout VTRS & political exposure

Does Viatris Inc. (VTRS) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Viatris Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own VTRS stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in VTRS on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded VTRS stock?
72 congressional trades by 15 unique members of Congress, most recently on 2025-11-18. See the Congressional Trading panel for politician-by-politician breakdown.
What is VTRS political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track VTRS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. VTRS data is updated daily from these official federal sources.